Cargando…
Comparing cancer drug approval systems in the United States and Japan
Autores principales: | Kaneda, Yudai, Maeda, Hideki, Ozaki, Akihiko, Higuchi, Yuka, Tanimoto, Tetsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170880/ https://www.ncbi.nlm.nih.gov/pubmed/37181668 http://dx.doi.org/10.1002/hsr2.1265 |
Ejemplares similares
-
Japan's COVID‐19 treatment strategy: An examination of approved oral medications
por: Higuchi, Yuka, et al.
Publicado: (2023) -
The unprecedented avian influenza crisis in Japan: Strategies for prevention and response
por: Kaneda, Yudai, et al.
Publicado: (2023) -
Are the issues pointed out by ChatGPT can be applied to Japan? - Examining the reasons behind high COVID-19 excess deaths in Japan
por: Kaneda, Yudai, et al.
Publicado: (2023) -
Revisiting Japan's early COVID‐19 countermeasures
por: Kaneda, Yudai, et al.
Publicado: (2023) -
Rethinking Japan’s Infallibility Principle for a Better Pandemic Response
por: Kaneda, Yudai, et al.
Publicado: (2023)